M-ARS ACL Post-marketing Surveillance Study

Launched by MEDACTA INTERNATIONAL SA · Jul 2, 2020

Keywords

ClinConnect Summary

The M-ARS ACL Post-marketing Surveillance Study is examining a specific surgical technique called Medacta Anatomic Ribbon Surgery (M-ARS), which is used to repair a torn anterior cruciate ligament (ACL) in the knee. The main goal of this study is to see how well this surgery works six months after it is performed. Researchers will also look at how patients are doing one month, one year, and two years after the surgery, focusing on their overall recovery, quality of life, and any complications that may arise.

To participate in this study, you need to be over 18 years old and have an ACL tear that requires surgical reconstruction. However, if you have certain health issues like cancer, infections, or allergies to the materials used in the surgery, you may not be eligible. If you join the study, you will be monitored closely after your surgery to help us understand how effective this procedure is for patients like you. This research will help improve treatment options for future ACL injuries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients older than 18 years
• • Patients with ACL rupture requiring ACL reconstruction
• Exclusion Criteria:
• • Patients with malignant diseases (at the time of surgery)
• • Patients with proven or suspected infections (at the time of surgery)
• • Patients with functional deficits of the affected extremity (at the time of surgery)
• • Patients with known incompatibility or allergy to products materials (at the time of surgery)